- Home
- ANTE vs DRMA Comparison
ANTE vs DRMA Comparison
Compare ANTE & DRMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ANTE
- DRMA
- Stock Information
- Founded
- ANTE 2005
- DRMA 2014
- Country
- ANTE China
- DRMA United States
- Employees
- ANTE N/A
- DRMA N/A
- Industry
- ANTE Advertising
- DRMA Biotechnology: Pharmaceutical Preparations
- Sector
- ANTE Consumer Discretionary
- DRMA Health Care
- Exchange
- ANTE Nasdaq
- DRMA Nasdaq
- Market Cap
- ANTE 6.7M
- DRMA 6.1M
- IPO Year
- ANTE N/A
- DRMA 2021
- Fundamental
- Price
- ANTE $0.54
- DRMA $1.25
- Analyst Decision
- ANTE
- DRMA Strong Buy
- Analyst Count
- ANTE 0
- DRMA 1
- Target Price
- ANTE N/A
- DRMA $6.00
- AVG Volume (30 Days)
- ANTE 117.9K
- DRMA 465.7K
- Earning Date
- ANTE 09-30-2024
- DRMA 03-20-2025
- Dividend Yield
- ANTE N/A
- DRMA N/A
- EPS Growth
- ANTE N/A
- DRMA N/A
- EPS
- ANTE 2.64
- DRMA N/A
- Revenue
- ANTE $500,000.00
- DRMA N/A
- Revenue This Year
- ANTE N/A
- DRMA N/A
- Revenue Next Year
- ANTE N/A
- DRMA N/A
- P/E Ratio
- ANTE $0.20
- DRMA N/A
- Revenue Growth
- ANTE N/A
- DRMA N/A
- 52 Week Low
- ANTE $0.26
- DRMA $1.00
- 52 Week High
- ANTE $2.90
- DRMA $7.62
- Technical
- Relative Strength Index (RSI)
- ANTE 62.42
- DRMA 52.68
- Support Level
- ANTE $0.42
- DRMA $1.00
- Resistance Level
- ANTE $0.58
- DRMA $1.28
- Average True Range (ATR)
- ANTE 0.03
- DRMA 0.09
- MACD
- ANTE 0.01
- DRMA 0.01
- Stochastic Oscillator
- ANTE 75.00
- DRMA 74.07
About ANTE AirNet Technology Inc.
AirNet Technology Inc provides in-flight solutions to connectivity, entertainment, and digital multimedia in China. It offers Internet connections through a network of satellites and land-based beacons, provides airline travelers with interactive entertainment, and breaking news, and furnishes corporate clients with advertisements tailored to the perceptions of the travelers. The revenues are mainly derived from selling advertising time slots on the companies advertising networks and cryptocurrency mining.
About DRMA Dermata Therapeutics Inc.
Dermata Therapeutics Inc is a clinical-stage medical dermatology company focused on identifying, developing, and commercializing pharmaceutical product candidates for the treatment of medical and aesthetic skin conditions and diseases. Its two product candidates, DMT310 and DMT410, incorporate its proprietary, multifaceted, Spongilla technology to topically treat a variety of dermatological conditions. Its Spongilla technology platform will enable to develop and formulate singular and combination products that are able to target topical delivery of chemical compounds into the dermis for maximum treatment effect for a variety of inflammatory skin diseases.